|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/689 | (2018.01) |
| C12Q 1/6883 | (2013.01) | ||
| C12Q 1/6883 | (2018.01) | ||
| C12Q2600/106 | (2013.01) | ||
| A61P 43/00 | (2006.01) | ||
| C12Q2600/156 | (2013.01) | ||
| A61P 31/04 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| C12Q 1/689 | (2013.01) |
| (11) | Patento numeris | 3555303 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17881986.8 |
| Europos patento paraiškos padavimo data | 2017-12-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-10-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-12-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/064985 |
| Data | 2017-12-07 |
| (87) | Numeris | WO 2018/111662 |
| Data | 2018-06-21 |
| (30) | Numeris | Data | Šalis |
| PCT/CN2016/109900 | 2016-12-14 | WO | |
| 201762508066 P | 2017-05-18 | US |
| (72) |
SHAW, Peter, M. , US
MEHROTRA, Devan, V. , US
BLANCHARD, Rebecca, L. , US
SHEN, Judong , US
MOGG, Robin , US
DORR, Mary Beth , US
LI, Junhua , CN
XU, Xun , CN
|
| (73) |
Merck Sharp & Dohme Corp. ,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
Beijing Genomics Institute at Shenzhen , Main Building Beishan Industrial Zone Yantian District, Shenzhen, Guangdong 518083, CN |
| (54) | HUMAN GENETIC MARKERS ASSOCIATED WITH RESPONSE TO TREATMENTS THAT TARGET CLOSTRIDIUM DIFFICILE TOXIN B |
| HUMAN GENETIC MARKERS ASSOCIATED WITH RESPONSE TO TREATMENTS THAT TARGET CLOSTRIDIUM DIFFICILE TOXIN B |